Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Virtus LifeSci Biotech Clinical Trials ETF (NY:BBC)

16.18 -0.30 (-1.82%)
Streaming Delayed Price Updated: 9:53 AM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Virtus LifeSci Biotech Clinical Trials ETF

CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode
The company reported revenue of €14.5 million for the fourth quarter, representing a decrease of €8.1 million from the corresponding period of 2023, and below an analyst estimate of €20.58, according... 
Via Stocktwits
Topics Government
Exposures Political
Why Is uniQure Stock Skyrocketing On Tuesday?
uniQure stock surges after FDA agrees on an accelerated approval pathway for its Huntington's disease treatment, AMT-130. 
Via Benzinga
Exposures Product Safety
Inflation Cools In June, Triggers Spike In Laggard ETFs
ETFs from some beaten-down corners of the market saw smooth trading following the inflation data. 
Via Talk Markets
Topics ETFs Economy
Exposures Interest Rates
5 ETFs Riding High On The Biotech Comeback
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off. 
Via Talk Markets
Biotech ETF Tops in June: 5 Stocks That Outperform
Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%. 
Via Talk Markets
4 Sector ETFs That Survived Market Turmoil in June
Despite the broad indices’ losses, a few sector ETFs survived the turmoil. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.